|
1
|
Zierath D, Thullbery M, Hadwin J, Gee JM,
Savos A, Kalil A and Becker KJ: CNS immune responses following
experimental stroke. Neurocrit Care. 12:274–284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakase T, Yamazaki T, Ogura N, Suzuki A
and Nagata K: The impact of inflammation on the pathogenesis and
prognosis of ischemic stroke. J Neurol Sci. 271:104–109. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Q, Tang XN and Yenari MA: The
inflammatory response in stroke. J Neuroimmunol. 184:53–68. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
ShenharTsarfaty S, Assayag EB, Bova I,
Shopin L, Berliner S, Shapira I and Bornstein NM: Early signaling
of inflammation in acute ischemic stroke: Clinical and rheological
implications. Thromb Res. 122:167–173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McColl BW, Allan SM and Rothwell NJ:
Systemic inflammation and stroke: Aetiology, pathology and targets
for therapy. Biochem Soc Trans. 35:1163–1165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sotgiu S, Zanda B, Marchetti B, Fois ML,
Arru G, Pes GM, Salaris FS, Arru A, Pirisi A and Rosati G:
Inflammatory biomarkers in blood of patients with acute brain
ischemia. Eur J Neurol. 13:505–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harms H, Prass K, Meisel C, Klehmet J,
Rogge W, Drenckhahn C, Göhler J, Bereswill S, Göbel U, Wernecke KD,
et al: Preventive antibacterial therapy in acute ischemic stroke: A
randomized controlled trial. PLoS One. 3:e21582008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schwarz S, Al-Shajlawi F, Sick C, Meairs S
and Hennerici MG: Effects of prophylactic antibiotic therapy with
mezlocillin plus sulbactam on the incidence and height of fever
after severe acute ischemic stroke: The Mannheim Infection in
Stroke Study (MISS). Stroke. 39:1220–1227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ad Hoc Committee representing the National
Stroke Foundation and the Stroke Society of Australasia: The
implementation of intravenous tissue plasminogen activator in acute
ischaemic stroke - a scientific position statement from the
National Stroke Foundation and the Stroke Society of Australasia.
Intern Med J. 39:317–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
AdamsHP Jr, del Zoppo G, Alberts MJ, Bhatt
DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C,
et al: Guidelines for the early management of adults with ischaemic
stroke: A guideline from the American Heart Association/American
Stroke Association Stroke Council, Clinical Cardiology Council,
Cardiovascular Radiology and Intervention Council and the
Atherosclerotic Peripheral Vascular Disease and Quality of Care
Outcomes in Research Interdisciplinary Working Groups: The American
Academy of Neurology affirms the value of this guideline as an
educational tool for neurologists. Stroke. 38:1655–1711. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
AdamsHP Jr, Bendixen BH, Kappelle LJ,
Biller J, Love BB, Gordon DL and Marsh EE III: Classification of
subtype of acute ischemic stroke. Definitions for use in a
multicenter clinical trial. TOAST. Trial of Org 10172 in Acute
Stroke Treatment. Stroke. 24:35–41. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Naess H, Idicula T, Lagallo N, Brogger J,
WajeAndreassen U and Thomassen L: Inverse relationship of baseline
body temperature and outcome between ischemic stroke patients
treated and not treated with thrombolysis: The Bergen stroke study.
Acta Neurol Scand. 122:414–417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saini M, Saqqur M, Kamruzzaman A, Lees KR
and Shuaib A: VISTA Investigators: Effect of hyperthermia on
prognosis after acute ischemic stroke. Stroke. 40:3051–3059. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greer DM, Funk SE, Reaven NL, Ouzounelli M
and Uman GC: Impact of fever on outcome in patients with stroke and
neurologic injury: A comprehensive meta-analysis. Stroke.
39:3029–3035. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leira R, Sobrino T, Blanco M, Campos F,
Rodríguez-Yáñez M, Castellanos M, Moldes O, Millán M, Dávalos A and
Castillo J: A higher body temperature is associated with
haemorrhagic transformation in patients with acute stroke untreated
with recombinant tissue-type plasminogen activator (rtPA). Clin Sci
(Lond). 122:113–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Lim LL, Levi C, Heller RF and
Fisher J: Influence of admission body temperature on stroke
mortality. Stroke. 31:404–409. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kammersgaard LP, Jørgensen HS, Rungby JA,
Reith J, Nakayama H, Weber UJ, Houth J and Olsen TS: Admission body
temperature predicts long-term mortality after acute stroke: The
Copenhagen Stroke Study. Stroke. 33:1759–1762. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karaszewski B, Thomas RG, Dennis MS and
Wardlaw JM: Temporal profile of body temperature in acute ischemic
stroke: Relation to stroke severity and outcome. BMC Neurol.
12:1232012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
den Hertog HM, van der Worp HB, van Gemert
HM, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ and Dippel DW:
An early rise in body temperature is related to unfavorable outcome
after stroke: Data from the PAIS study. J Neurol. 258:302–307.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leira R, Rodríguez-Yáñez M, Castellanos M,
Blanco M, Nombela F, Sobrino T, Lizasoain I, Dávalos A and Castillo
J: Hyperthermia is a surrogate marker of inflammation-mediated
cause of brain damage in acute ischaemic stroke. J Intern Med.
260:343–349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hurn PD, Subramanian S, Parker SM,
Afentoulis ME, Kaler LJ, Vandenbark AA and Offner H: T- and
B-cell-deficient mice with experimental stroke have reduced lesion
size and inflammation. J Cereb Blood Flow Metab. 27:1798–1805.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith CJ, Emsley HC, Gavin CM, Georgiou
RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ,
Hopkins SJ and Tyrrell PJ: Peak plasma interleukin-6 and other
peripheral markers of inflammation in the first week of ischaemic
stroke correlate with brain infarct volume, stroke severity and
long-term outcome. BMC Neurol. 4:22004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Christensen H and Boysen G: C-reactive
protein and white blood cell count increases in the first 24 h
after acute stroke. Cerebrovasc Dis. 18:214–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akopov SE, Simonian NA and Grigorian GS:
Dynamics of polymorphonuclear leukocyte accumulation in acute
cerebral infarction and their correlation with brain tissue damage.
Stroke. 27:1739–1743. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
EliasSmale SE, Kardys I, Oudkerk M, Hofman
A and Witteman JC: C-reactive protein is related to extent and
progression of coronary and extra-coronary atherosclerosis; results
from the Rotterdam study. Atherosclerosis. 195:e195–e202. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ridker PM, Danielson E, Fonseca FA, Genest
J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ,
MacFadyen JG, et al: Rosuvastatin to prevent vascular events in men
and women with elevated C-reactive protein. N Engl J Med.
359:2195–2207. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Idicula TT, Brogger J, Naess H,
WajeAndreassen U and Thomassen L: Admission C-reactive protein
after acute ischemic stroke is associated with stroke severity and
mortality: The ‘Bergen stroke study’. BMC Neurol. 9:182009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
den Hertog HM, van Rossum JA, van der Worp
HB, van Gemert HM, de Jonge R, Koudstaal PJ and Dippel DW: PAIS
investigators: C-reactive protein in the very early phase of acute
ischemic stroke: Association with poor outcome and death. J Neurol.
256:2003–2008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hacke W, Kaste M, Bluhmki E, Brozman M,
Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, et
al: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic
stroke. N Engl J Med. 359:1317–1329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Audebert HJ, Rott MM, Eck T and Haberl RL:
Systemic inflammatory response depends on initial stroke severity
but is attenuated by successful thrombolysis. Stroke. 35:2128–2133.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hemmen TM, Raman R, Guluma KZ, Meyer BC,
Gomes JA, CruzFlores S, Wijman CA, Rapp KS, Grotta JC and Lyden PD:
ICTuS-L Investigators: Intravenous thrombolysis plus hypothermia
for acute treatment of ischemic stroke (ICTuS-L): Final results.
Stroke. 41:2265–2270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Idicula TT, WajeAndreassen U, Brogger J,
Naess H, Lundstadsveen MT and Thomassen L: The effect of
physiologic derangement in patients with stroke treated with
thrombolysis. J Stroke Cerebrovasc Dis. 17:141–146. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Millan M, Grau L, Castellanos M,
Rodríguez-Yáñez M, Arenillas JF, Nombela F, Pérez de la Ossa N,
López-Manzanares L, Serena J, Castillo J and Dávalos A: Body
temperature and response to thrombolytic therapy in acute ischaemic
stroke. Eur J Neurol. 15:1384–1389. 2008. View Article : Google Scholar : PubMed/NCBI
|
